Deva Holding AS (IST:DEVA) Research & Development: ₺1,021 Mil (TTM As of Mar. 2026)


IST:DEVA Deva Holding AS IST:DEVA
66 GF Score
Price ₺70.10
GF Value ₺80.83
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Deva Holding AS Research & Development?

Deva Holding AS IST:DEVA +0.43% 66 Research & Development is ₺1,021 Mil as of Mar. 2026. GuruFocus rates IST:DEVA with a GF Score™ of 66/100 and a GF Value™ of ₺80.83 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Deva Holding AS's Research & Development for the three months ended in Mar. 2026 was ₺338 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₺1,021 Mil.

Deva Holding AS  (IST:DEVA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Deva Holding AS Research & Development Related Terms

Deva Holding AS Research & Development Historical Data

* Premium members only.

The historical data trend for Deva Holding AS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Deva Holding AS Research & Development Chart

Deva Holding AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.97 312.54 1,548.26 813.82 1,001.56

Deva Holding AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 344.44 244.63 264.29 174.34 338.10
IST:DEVA
66GF Score
Deva Holding AS IST:DEVA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Deva Holding AS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺1,021 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₺1,021 Mil mean?
Deva Holding AS (IST:DEVA) has a Research & Development of ₺1,021 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Deva Holding AS and its competitors.
Is Deva Holding AS's Research & Development too high?
Deva Holding AS's current Research & Development is ₺1,021 Mil. Overall, Deva Holding AS has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Deva Holding AS's Research & Development compare to ZTS and UTHR?
Deva Holding AS's Research & Development of ₺1,021 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Deva Holding AS and its competitors. Deva Holding AS's current Research & Development is ₺1,021 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Deva Holding AS stock overvalued right now?
Based on GuruFocus' analysis, Deva Holding AS (IST:DEVA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₺80.83, compared to a current price of ₺70.10 — trading 13.3% below its estimated fair value. The current Research & Development is ₺1,021 Mil. Deva Holding AS's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Deva Holding AS (IST:DEVA), the current Research & Development is ₺1,021 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Deva Holding AS (IST:DEVA) Overvalued in 2026?

Based on GuruFocus' analysis, Deva Holding AS stock appears to be undervalued. The current stock price of ₺70.10 is trading 13.3% below its estimated GF Value™ of ₺80.83. GuruFocus considers Deva Holding AS to be Modestly Undervalued.

Key valuation signals for IST:DEVA:

  • Research & Development: ₺1,021 Mil
  • GF Value™: ₺80.83 vs. price of ₺70.10 (13.3% below fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the IST:DEVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Deva Holding AS Business Description

Address Halkali Merkez Mahallesi, Basin Ekspres Caddesi No. 1, Kucukcekmece, Istanbul, TUR
Deva Holding AS is a Turkey-based generic medicine manufacturer. It is engaged in manufacturing and marketing of medicinal products for human use and raw materials. The company also carries out the manufacturing of veterinary drugs, eau de cologne, and medical ampoules. It produces medicines for antineoplastic agents, cardiovascular system, dermatological products, nervous system, respiratory system, urogenital system, among others. It exports pharmaceuticals and pharmaceutical raw materials in countries including Switzerland, Germany, the Netherlands, the United Kingdom and others.
66GF Score

Get the complete analysis for IST:DEVA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺70.10
Price
₺80.83
GF Value